An Ohio surgical resident who crushed abortion pills and forced them on his sleeping girlfriend, ending her pregnancy without her knowledge or consent, will spend only six months behind bars. The sentence has drawn sharp criticism from pro-life leaders who say the case exposes a dangerous gap in how federal regulators handle the very drugs that made the crime possible.
Hassan-James Abbas, a medical professional entrusted with the health of patients, pleaded no contest to four felony charges in connection with the forced abortion. A judge sentenced him to six months at the Corrections Center of Northwest Ohio, followed by two years of probation. The State Medical Board of Ohio has suspended his medical training certificate.
Abbas obtained the drugs mifepristone and misoprostol from an out-of-state online provider. To place the order, he stole the personal information of his estranged wife and used her identity, Breitbart reported. He then crushed the pills and administered them to his girlfriend while she slept.
The woman lost her baby.
Abbas later admitted to crushing and giving her the pills but falsely claimed she had consented. His girlfriend told the outlet she fought to escape him and tried to call 911. Abbas took her phone and disconnected her from emergency services.
The four felony charges to which Abbas pleaded no contest tell the story of a scheme that touched multiple areas of criminal law: disrupting public services, unlawful distribution of an abortion-inducing drug, identity fraud, and deception to obtain a dangerous drug. Each charge reflects a distinct act of calculated deception, from stealing his estranged wife's identity to blocking his girlfriend's 911 call.
The sentence landed with a thud among advocates who expected the gravity of four felony counts to produce a longer term of incarceration. Six months in a county corrections facility, followed by community supervision, struck pro-life leaders as a fraction of what the conduct warranted.
Fox News reported on the reaction from Susan B. Anthony Pro-Life America, whose president, Marjorie Dannenfelser, framed the case within a broader pattern of coerced chemical abortions enabled by loose federal oversight of mifepristone distribution.
Dannenfelser did not mince words about what she sees as the downstream consequences of current FDA policy on mail-order abortion pills:
"Pro-life laws enacted following the Dobbs victory are effectively nullified, 15,000 babies in states with pro-life laws are killed every month, and women suffer physical and mental consequences in addition to abuse and coercion."
Her organization has tracked nearly 20 cases nationwide in which partners have been charged with or convicted of poisoning pregnant women with mifepristone, Just The News reported. The Abbas case is one data point in a pattern that pro-life groups say is growing and that federal regulators have been slow to confront.
Louisiana alone has produced three known criminal cases of alleged mifepristone coercion. In one recent case, Jamelle Kelly, 39, was arrested for allegedly causing his daughter to unknowingly take the pill at 23 weeks of pregnancy. That incident resulted in emergency cesarean surgery and a baby born weighing one pound.
The Louisiana cases and the Abbas prosecution share a common thread: the drugs arrived through channels that operate largely outside traditional in-person medical oversight. Abbas ordered his supply online, from out of state, using a stolen identity. The ease of that transaction is central to the policy debate now playing out in federal court.
Louisiana has pushed for expedited judicial review of FDA regulations governing mail-order distribution of mifepristone. The federal government has opposed faster court review, even as the FDA conducts its own ongoing safety review of the drug. That tension between state-level urgency and federal procedural resistance defines the current legal landscape for abortion pill regulation.
Federal regulations limit mifepristone dispensing to pregnancies of 10 weeks' gestational age or less. But that limit exists largely on paper. Four in five providers within the formal U.S. healthcare system that publicly report gestational age limits are exceeding the FDA's 10-week regulatory window, Just The News reported.
That statistic carries weight in the Abbas case and others like it. If legitimate providers routinely exceed the FDA's own safety threshold, the argument for tighter controls on unregulated online sales gains force. Abbas, a trained physician, knew exactly what the drugs would do. He exploited a distribution system that asked few questions and verified little.
Investigators and courts will need to determine whether the online provider that filled Abbas's order bears any legal exposure for the transaction. Authorities have not publicly confirmed whether that provider has faced scrutiny or whether the stolen identity triggered any verification failure on the seller's end.
The status of Abbas's medical career beyond the current suspension also remains an open question. The State Medical Board of Ohio suspended his training certificate, but investigators have not said whether permanent revocation proceedings are underway or whether other jurisdictions where Abbas may hold credentials have taken action.
His girlfriend survived physically. The broader toll of what she endured, from the loss of her pregnancy to the struggle to reach 911 while Abbas held her phone, sits at the center of a case that pro-life advocates want the public to remember when the FDA's mifepristone rules come up for review.
The Abbas sentencing arrives at a moment when two forces are pulling in opposite directions. Pro-life organizations and several state attorneys general want tighter controls on chemical abortion drugs, especially the mail-order pipeline that made Abbas's crime logistically simple. Federal agencies, meanwhile, have resisted accelerating the judicial timeline for reviewing those very rules.
Dannenfelser and SBA Pro-Life America argue that the post-Dobbs promise of state-level abortion protections is hollow if mifepristone flows freely across state lines through online pharmacies that cannot verify who is ordering, who will take the pills, or whether consent exists. Nearly 20 criminal cases suggest that the drugs are reaching people who weaponize them.
Courts will ultimately decide whether the FDA's current framework can survive legal challenge. But for the woman in Ohio who woke up to discover what Abbas had done, that procedural timeline offers cold comfort.
When a doctor can order abortion drugs under a stolen name, force them on a sleeping woman, block her 911 call, and walk out of a courtroom facing six months, the system has a gap. The only question is whether anyone with the authority to close it has the will to act.
